Cuprina Holdings (Cayman) Limited Class A Ordinary Shares (CUPR) Stock Price, Financials & Summary

Price chart

Aug 6Aug 11Aug 14Aug 19Aug 24Aug 27Sep 1Sep 4

ValuationView details →

P/E (Fwd)

—

EV/EBITDA

−1.8x

Market Cap

$8.45M

MomentumView details →

1D Return

+7.14%

YTD Return

−1.25%

RSI (14)

51.2

ValuationView details →

P/E (Fwd)

—

EV/EBITDA

−1.8x

Market Cap

$8.45M

RSI (14)

51.2

MomentumView details →

1D Return

+7.14%

YTD Return

−1.25%

SummaryUpdated Dec 1, 2025

Cuprina Holdings (Cayman) Limited (NASDAQ:CUPR) is a Singapore-based biomedical and biotechnology company that went public in April 2025. Founded as a specialized developer of innovative wound care solutions, the company has positioned itself at the intersection of biotechnology and medical device manufacturing. Cuprina operates primarily in the chronic wound management sector, developing and commercializing biological products for healthcare applications, while also maintaining a presence in the cosmeceutical market.

Ask drillr about Cuprina Holdings (Cayman) Limited Class A Ordinary Shares →

ProfitabilityView details →

Gross Margin

−1.29%

Net Margin

−9366.75%

EBITDA Margin

−9137.07%

ROE (TTM)

−92.44%

ROA (TTM)

−54.95%

Asset Turnover

0.01x

GrowthView details →

Revenue YoY

—

EPS YoY

—

FCF YoY

—

Revenue CAGR 3Y

−4.12%

EPS CAGR 3Y

—

EBITDA YoY

—

EarningsView details →

EPS (Actual)

—

EPS Surprise

—

Beats (12Q)

—

Next Q EPS Est

—

Avg Surprise (4Q)

—

Rev Surprise

—

Capital & dividendView details →

Debt/Equity

0.10x

Current Ratio

2.35x

Quick Ratio

2.35x

Div Yield

—

Div Rate

—

Div Growth 1Y

—

Financials snapshotView financials →

Revenue (TTM)

—

Net Income (TTM)

—

Op. CF (TTM)

—

Latest newsMore news →

No recent news for CUPR.

Similar companies

Exicure, Inc.XCUR Traws Pharma, Inc.TRAW Skye Bioscience, Inc.SKYE CNS Pharmaceuticals, Inc.CNSP Soligenix, Inc.SNGX COSCIENS Biopharma Inc.CSCI Find similar companies →

Latest newsMore news →

No recent news for CUPR.